Cresco Labs Inc. (CRLBF) stock
CRLBFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.58−0.02 (-3.13%)
Close on Oct 19, 2026Market cap –P/E –Yield –
Cresco Labs gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2025 it was $324.57M, down 10.9% from the year before. The highest annual figure on record is $407.01M in fiscal 2022.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $324.57M | -10.9% |
| FY2024 | Dec 31, 2024 | $364.45M | +0.6% |
| FY2023 | Dec 31, 2023 | $362.37M | -11.0% |
| FY2022 | Dec 31, 2022 | $407.01M | +0.2% |
| FY2021 | Dec 31, 2021 | $406.35M | +96.6% |
| FY2020 | Dec 31, 2020 | $206.70M | +353.0% |
| FY2019 | Dec 31, 2019 | $45.63M | – |
See a number that looks wrong?